New Posts

Feb 8, 2016

Top 400 Taxpayers See Tax Rates Rise, But There’s More to the Story

As Americans were gathering party supplies to greet the New Year, the Internal Revenue Service released their annual report of cumulative tax data reported on the 400 tax r...

read in full
Feb 4, 2016

Chlorine Bleach Plants Needlessly Endanger 63 Million Americans

Chlorine bleach plants across the U.S. put millions of Americans in danger of a chlorine gas release, a substance so toxic it has been used as a chemical weapon. Greenpeace’s new repo...

read in full
Jan 25, 2016

U.S. Industrial Facilities Reported Fewer Toxic Releases in 2014

The Toxics Release Inventory (TRI) data for 2014 is now available. The good news: total toxic releases by reporting facilities decreased by nearly six percent from 2013 levels. Howe...

read in full
Jan 22, 2016

Methane Causes Climate Change. Here's How the President Plans to Cut Emissions by 40-45 Percent.

  UPDATE (Jan. 22, 2016): Today, the Bureau of Land Management (BLM) released its proposed rule to reduce methane emissions...

read in full
more news

For Congress, an Opportunity to Limit Conflicts of Interest at FDA

Yesterday, Reg•Watch blogged about Congress's FDA reform bill which has passed the House and the Senate but is now stuck in a conference committee charged with reconciling the two versions.

read in full

Latest Watcher

Be sure to check out the latest issue of our biweekly newsletter, The Watcher. Regulatory policy articles this time: Federal Agencies Knew of Diacetyl Dangers and Kept Silent Bush's Anti-Regulatory Ideology under Increasing Scrutiny It's Industry vs. Consumers and Health Specialists in National Ozone Hearings

read in full

Startling Increase in Adverse Effects of Drugs

Yesterday, The Chicago Tribune published a story about a new medical study that has found a dramatic increase in adverse effects associated with prescription drugs. According to the article, "The annual number of 'serious adverse event' reports jumped to 89,842 in 2005 from 34,966 in 1998. Meanwhile, the number of 'fatal adverse drug events' increased nearly threefold to 15,107 in 2005 from 5,519 in 1998."

read in full

It's Industry vs. Consumers and Health Specialists in National Ozone Hearings

Recent field hearings in five major U.S. cities highlighted the debate over the need to write a more stringent air quality standard for ozone. The U.S. Environmental Protection Agency (EPA) is under court order to issue an updated standard by March 2008. Industry representatives used two familiar arguments to urge EPA to leave the existing ten-year old ozone standard untouched, while public health experts and citizens argued the health impacts under the current standard are potentially devastating.

read in full

New Small Business Program Will Influence Agency Regulatory Reviews

The Small Business Administration's (SBA) Office of Advocacy has launched a new program that may expand SBA's influence into agency regulatory activity. The Office of Advocacy acts as a liaison between the business community and the federal government, particularly the executive branch.

read in full

Bush's Anti-Regulatory Ideology under Increasing Scrutiny

The public and the media are paying more attention to and showing increasing frustration with the anti-regulatory ideology of President George W. Bush. A new report by the Center for American Progress traces several recent failures of the federal government to the anti-government views of Bush and senior administration officials. Separately, increasing concern over the federal product safety net is causing many to question Bush's seriousness about using government resources to protect American consumers.

read in full

The Other Surge: Regulatory Activity at the End of a Presidency

An article in yesterday's New York Times describes how President Bush has started a flurry of 11th hour regulatory activity. Every president since John Adams has used the waning days of his presidency to issue executive edicts and final regulations in order to ensure his policy beliefs outlast his days in the White House. The article mentions the environmentally damaging mountaintop mining rule the administration proposed last month (click here for details) as a precursor of things to come.

read in full

Reform Bill Sent to President and is Expected to Sign

The lobbying and ethics reform bill, S.1, was finally sent to President Bush Sept. 4, and Bush is expected to sign the measure into law early next week. This comes after the bill was withheld from the president out of concern of a possible veto. The president reportedly has concerns over the earmark provisions and the revolving door provisions.

read in full

Is Barbie above the Law?

Mattel is recalling another batch of toys because of lead paint contamination. This time, it's 675,000 Barbie toys. As it has with past recalls, Mattel is working in cooperation with the Consumer Product Safety Commission, the federal agency responsible for regulating toys and other products. Reg•Watch has blogged about the problems with this industry-lead voluntary recall system and the ineffectiveness of CPSC.

read in full

Senate to Vote on Nussle for OMB Director

The Senate is debating the nomination of Jim Nussle to be the director of the White House Office of Management and Budget. (Watch the debate on C-SPAN here.) OMB Watch has issued a statement on Jim Nussle. Among other things, OMB Watch urges Nussle to "work toward ensuring greater transparency within the agencies and the White House and to stimulate public participation in the rulemaking process" and to "lead an OMB respectful of agencies' scientific and technical expertise and to focus on providing adequate resources rather than additional analytical burdens."

read in full

Pages

Resources & Research

Living in the Shadow of Danger: Poverty, Race, and Unequal Chemical Facility Hazards

People of color and people living in poverty, especially poor children of color, are significantly more likely...

read in full

A Tale of Two Retirements: One for CEOs and One for the Rest of Us

The 100 largest CEO retirement funds are worth a combined $4.9 billion, equal to the entire retirement account savings of 41 percent of American fam...

read in full
more resources